We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GYRE icon
1926
Gyre Therapeutics
GYRE
$744M
$29K ﹤0.01%
538
+515
+2,239% +$32.2K
HLI icon
1927
Houlihan Lokey
HLI
$9.02B
$29K ﹤0.01%
+650
New +$30.4K
IOVA icon
1928
Iovance Biotherapeutics
IOVA
$2.87B
$29K ﹤0.01%
+1,200
New +$18.1K
SFBS
1929
ServisFirst Bancshares
SFBS
$4.86B
$29K ﹤0.01%
838
+87
+12% +$2.91K
TOWN icon
1930
Towne Bank
TOWN
$3.42B
$29K ﹤0.01%
+1,066
New +$28.1K
TRGP icon
1931
Targa Resources
TRGP
$55.1B
$29K ﹤0.01%
746
-1,594
-68% -$63.3K
TWO
1932
Two Harbors Investment
TWO
$1.27B
$29K ﹤0.01%
575
-1,618
-74% -$85K
QUOT
1933
DELISTED
Quotient Technology Inc
QUOT
$29K ﹤0.01%
2,730
-1,628
-37% -$16.5K
CCXI
1934
DELISTED
ChemoCentryx, Inc.
CCXI
$29K ﹤0.01%
+3,106
New +$36K
VRTU
1935
DELISTED
Virtusa Corporation
VRTU
$29K ﹤0.01%
644
+607
+1,641% +$29.6K
DLPH
1936
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$29K ﹤0.01%
1,445
-3,156
-69% -$64.6K
ASR icon
1937
Grupo Aeroportuario del Sureste
ASR
$8.3B
$28K ﹤0.01%
173
-1,311
-88% -$214K
BFS
1938
Saul Centers
BFS
$841M
$28K ﹤0.01%
498
-2,317
-82% -$126K
CX icon
1939
Cemex
CX
$16.3B
$28K ﹤0.01%
6,650
-30,282
-82% -$135K
CYCN icon
1940
Cyclerion Therapeutics
CYCN
$16.7M
$28K ﹤0.01%
+121
New +$34.2K
DORM icon
1941
Dorman Products
DORM
$4.18B
$28K ﹤0.01%
+321
New +$27.9K
EFC
1942
Ellington Financial
EFC
$1.71B
$28K ﹤0.01%
1,550
+808
+109% +$14.6K
HBIO icon
1943
Harvard Bioscience
HBIO
$29.2M
$28K ﹤0.01%
1,375
+1,101
+402% +$32.3K
HIG icon
1944
Hartford Financial Services
HIG
$39.3B
$28K ﹤0.01%
515
-8,108
-94% -$428K
HYG icon
1945
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
$28K ﹤0.01%
318
+239
+303% +$20.6K
LGIH icon
1946
LGI Homes
LGIH
$1.4B
$28K ﹤0.01%
393
+40
+11% +$2.77K
MCRB icon
1947
Seres Therapeutics
MCRB
$48.9M
$28K ﹤0.01%
434
+422
+3,517% +$40.1K
MSBI icon
1948
Midland States Bancorp
MSBI
$695M
$28K ﹤0.01%
1,036
+401
+63% +$10.4K
MX icon
1949
Magnachip Semiconductor
MX
$145M
$28K ﹤0.01%
2,715
-12,608
-82% -$115K
NEO icon
1950
NeoGenomics
NEO
$2.13B
$28K ﹤0.01%
1,295
-18,526
-93% -$407K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.